Publications by authors named "Tonet Seres-Noriega"

Article Synopsis
  • The study investigates the link between cumulative tobacco consumption and atherosclerosis in patients with type 1 diabetes, focusing on its potential to enhance the Steno T1 Risk Engine (ST1RE) for identifying arterial plaques.
  • A total of 584 type 1 diabetes patients were examined, revealing a 40.9% prevalence of plaques, with cumulative tobacco use correlating with higher plaque counts even after adjusting for various health factors.
  • Although adding cumulative tobacco consumption to the ST1RE didn't significantly improve plaque identification overall, it did enhance detection specifically in active smokers, suggesting further research is necessary to understand its implications for atherosclerosis risk in type 1 diabetes.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how severe hypoglycemia (SH) and awareness of hypoglycemia are related to the early stages of atherosclerosis in individuals with type 1 diabetes (T1D).
  • It involved 634 patients without cardiovascular disease, evaluating their risk factors and using ultrasound to detect carotid plaque.
  • Results indicate that both a history of SH and hypoglycemia awareness scores are linked to preclinical atherosclerosis, suggesting they could help identify patients needing more aggressive treatment even when overall cardiovascular risk is low.
View Article and Find Full Text PDF
Article Synopsis
  • People with type 1 diabetes (T1D) face a higher risk of cardiovascular disease (CVD), and this study explored how following the energy-restricted Mediterranean diet (erMEDd) affects carotid atherosclerosis.
  • A total of 401 T1D patients were studied, and those with carotid plaques displayed lower adherence to the erMEDd compared to those without plaques.
  • The results indicate that better adherence to the Mediterranean diet is linked to less atherosclerosis, emphasizing the need for encouraging healthy eating habits in T1D patients, especially those at risk for CVD.*
View Article and Find Full Text PDF

People with type 1 diabetes (T1D) have a high cardiovascular disease (CVD) risk, which remains the leading cause of death in this population. Despite the improved control of several classic risk factors, particularly better glycaemic control, cardiovascular morbidity and mortality continue to be significantly higher than in the general population. In routine clinical practice, estimating cardiovascular risk (CVR) in people with T1D using scales or equations is often imprecise because much of the evidence comes from pooled samples of people with type 2 diabetes (T2D) and T1D or from extrapolations of studies performed on people with T2D.

View Article and Find Full Text PDF
Article Synopsis
  • Women with type 1 diabetes face a higher risk of cardiovascular events than men, and this study examines how preeclampsia and childbirth (parity) influence this discrepancy.
  • The study analyzed 728 participants, focusing on carotid plaque presence and cardiovascular risk using standardized ultrasonography and the Steno T1 Risk Engine.
  • Findings showed that women without a history of preeclampsia had a lower risk for carotid plaque compared to men, but adding obstetric factors to cardiovascular risk assessment did not enhance prediction accuracy.
View Article and Find Full Text PDF

Background And Aims: Recent studies have identified a relationship between innate versus. Adaptative immunity and cardiovascular disease (CVD) in the general population, but information on type 1 diabetes (T1D) is lacking. We aimed to study the relationship between inflammatory biomarkers and preclinical atherosclerosis in this population.

View Article and Find Full Text PDF

Introduction: An increased midnight cortisol (MC) has been described in end-stage kidney disease (ESKD) and type 1 diabetes (T1D). Lower circulating levels of the cytokine soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (sTWEAK) have been found in T1D and ESKD and associated with cardiovascular (CV) events in the latter. We aimed to study MC and sTWEAK in simultaneous pancreas-kidney transplant (SPKT) recipients, and the association of these markers with CV risk factors and transplant outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • People with type 1 diabetes (T1D) have problems with certain types of fats in their blood, which may increase their risk of heart disease.
  • A study looked at T1D patients who had no previous heart issues but were considered high-risk, finding that many had carotid plaques that could lead to heart problems.
  • The study showed that certain blood fat levels, especially those related to HDL and LDL, could help identify who is at the highest risk for heart disease in T1D patients.
View Article and Find Full Text PDF

Introduction: Cardiovascular disease (CVD) is the leading cause of mortality in type 1 diabetes (T1D). However, there is a need for daily practice tools for identifying those more prone to suffer from these events. We aimed to assess the relationships between nuclear magnetic resonance (H NMR)-based lipidomic analysis and several CVD risk variables (including preclinical carotid atherosclerosis) in individuals with T1D at high risk.

View Article and Find Full Text PDF

Introduction: The medical specialisation model in Spain is carried out in the context of specialised health training, through the residency programme. The aim of the study is to analyse, by an anonymous survey, the opinion on three aspects among final-year residents in Endocrinology and Nutrition (E&N): self-assessment of the knowledge acquired, working prospects, care and training consequences arising from the pandemic COVID-19.

Materials And Methods: Cross-sectional observational study using a voluntary and anonymous online survey, shared among final-year national interns in the last year of the E&N programme, carried out between June-July 2021.

View Article and Find Full Text PDF

Background And Aims: Although cardiovascular disease (CVD) remains the leading cause of mortality in type 1 diabetes (T1D), the use of cardioprotective drugs is scarce. We aimed to evaluate the impact of carotid ultrasonography (US) on the improvement in cardiovascular risk factors (CVRFs) in T1D.

Methods And Results: T1D patients without CVD meeting criteria for lipid treatment according to guidelines (age ≥ 40 years, nephropathy and/or ≥ 10 years of diabetes duration with ≥ 1 additional CVRFs) were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of diabetic neuropathy (DN) on outcomes after pancreas transplantation (PT) in patients with type 1 diabetes and end-stage kidney disease, focusing on graft survival and cardiovascular disease (CVD).
  • Researchers analyzed data from 187 individuals who underwent PT between 1999 and 2015, measuring vibration perception thresholds (VPTs) to assess DN before and after the procedure.
  • Results showed that while VPTs improved after PT, higher pretransplant VPTs were linked to a greater risk of graft failure and CVD, highlighting the importance of DN assessments in predicting posttransplant outcomes.
View Article and Find Full Text PDF

Objective: To evaluate the concordance between the 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (ESC/EASD-2019) and the Steno T1 Risk Engine (Steno-Risk) cardiovascular risk scales for individuals with type 1 diabetes (T1D) without cardiovascular disease (CVD) and to analyze the relationships of their use with identification of preclinical atherosclerosis.

Research Design And Methods: We consecutively selected patients with T1D, without CVD, age ≥40 years, with nephropathy, and/or with ≥10 years of T1D evolution with another risk factor. The presence of plaque at different carotid segments was determined by ultrasonography.

View Article and Find Full Text PDF

Aims: Evaluate the relationship between high and low exposure continuous glucose monitoring (CGM)-derived glucometrics and micro- and macrovascular complications in type 1 diabetes (T1D).

Methods: Cross-sectional study in T1D without cardiovascular disease (CVD) and with ≥ 1 of the following: ≥40 years, diabetic nephropathy, or ≥ 10 years of diabetes duration with CVD risk factors. Glucometrics were obtained over 14 consecutive days: glucose management indicator (GMI) and proportion of time < 54 (TBR < 54), <70, 70-180 (TIR), >180 (TAR).

View Article and Find Full Text PDF

Purpose: Information on the association between diet and cardiovascular disease (CVD) in type 1 diabetes (T1D) is scarce. We assessed the association between biomarkers of fatty acid (FA) intake and the presence of carotid plaques (a surrogate marker of future CVD events) in this high-risk population.

Methods: Cross-sectional study in 167 consecutive T1D patients without CVD and with at least one of the following: ≥ 40 years, diabetic nephropathy, or ≥ 10 years of T1D duration with another CVD risk factor.

View Article and Find Full Text PDF

Background And Aims: Glycoproteins play a key role in inflammatory and cardiometabolic processes. Their implication in atherosclerosis in type 1 diabetes (T1D) is unknown. We assessed the relationships between classic inflammatory markers, glycoproteins measured by nuclear magnetic resonance (H-NMR), and preclinical atherosclerosis in these patients.

View Article and Find Full Text PDF